Bajaj HealthCare

618.50
-13.00
(-2.06%)
Market Cap
1,953.42 Cr
EPS
-30.36
PE Ratio
45.65
Dividend Yield
0.14 %
Industry
Healthcare
52 Week High
719.00
52 Week low
263.30
PB Ratio
4.47
Debt to Equity
1.16
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,656.55 3,97,461.83 32.77 49,887.20 12.06 9,648 13.77 37.72
5,549.75 1,47,328.43 70.79 8,184.00 0.89 1,600 64.53 39.06
1,441.00 1,16,377.18 23.67 26,520.70 14.17 4,155 47.38 53.19
3,069.10 1,03,872.29 55.81 10,785.70 11.59 1,656 13.54 48.49
1,116.35 93,149.46 17.40 28,905.40 12.36 5,578 1.69 32.01
2,211.30 91,230.92 45.68 10,615.60 19.57 1,942 -16.38 36.72
899.90 90,551.00 19.82 19,831.50 13.82 3,831 29.92 43.14
1,974.75 90,087.61 31.98 20,141.50 19.94 1,936 38.82 48.40
30,600.00 65,022.86 48.79 6,097.20 10.80 1,201 16.01 59.83
1,090.00 63,307.38 18.00 29,559.20 17.55 3,169 -10.04 42.91
Growth Rate
Revenue Growth
-25.53 %
Net Income Growth
-122.52 %
Cash Flow Change
515.91 %
ROE
-129.80 %
ROCE
-82.65 %
EBITDA Margin (Avg.)
0.97 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
218
223
233
329
371
417
664
681
647
482
538
Expenses
190
193
200
288
328
362
521
561
534
397
484
EBITDA
29
30
33
41
44
55
143
120
113
85
54
Operating Profit %
13 %
13 %
13 %
12 %
12 %
12 %
21 %
17 %
17 %
16 %
8 %
Depreciation
9
9
11
11
11
12
16
18
17
28
28
Interest
8
8
8
8
8
6
8
13
18
30
28
Profit Before Tax
12
14
14
23
24
36
119
90
78
-17
-2
Tax
5
5
6
8
8
11
36
18
15
-2
0
Net Profit
8
8
8
15
16
25
83
71
64
-14
-2
EPS in ₹
11.13
12.15
11.37
22.01
11.82
18.29
30.11
25.87
15.59
-30.36
-1.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
189
209
219
268
283
343
526
721
898
765
Fixed Assets
109
130
128
127
156
162
208
270
366
253
Current Assets
79
78
91
140
124
168
258
398
500
405
Capital Work in Progress
1
2
0
2
1
5
57
52
22
7
Investments
0
0
0
0
0
5
0
0
0
0
Other Assets
79
78
91
140
126
170
261
399
510
506
Total Liabilities
189
209
219
268
283
343
526
721
898
765
Current Liabilities
85
88
93
131
111
138
183
322
434
402
Non Current Liabilities
22
32
28
23
19
27
85
71
96
85
Total Equity
82
89
99
114
153
178
258
329
368
278
Reserve & Surplus
78
82
92
107
146
164
245
315
354
265
Share Capital
4
7
7
7
7
14
14
14
14
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-0
1
7
-0
-4
10
-12
16
-16
Investing Activities
-17
-31
-8
-12
-13
-28
-109
-75
-93
-11
Operating Activities
28
25
22
17
25
21
44
1
-22
92
Financing Activities
-11
5
-13
3
-13
3
76
62
131
-97

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.30 %
67.30 %
67.42 %
67.49 %
67.49 %
67.69 %
67.73 %
67.73 %
67.73 %
59.19 %
59.19 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.66 %
0.74 %
0.53 %
0.01 %
1.07 %
1.01 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.34 %
0.34 %
0.34 %
0.44 %
0.48 %
0.44 %
0.00 %
1.97 %
2.36 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.79 %
12.67 %
13.95 %
13.95 %
14.85 %
16.53 %
16.71 %
16.50 %
16.67 %
16.45 %
16.80 %
18.44 %
19.45 %
19.91 %
20.17 %
25.52 %
26.94 %
Others
22.94 %
20.06 %
18.79 %
18.79 %
17.89 %
16.21 %
15.99 %
16.21 %
15.57 %
15.73 %
15.37 %
12.78 %
11.61 %
11.39 %
12.09 %
12.26 %
10.50 %
No of Share Holders
7,236
13,283
26,707
31,462
32,309
30,723
30,909
29,769
26,930
26,037
27,322
28,008
29,626
32,712
32,397
31,993
32,672

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
7 days ago
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
Feb 25, 2025, 12:57
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
Feb 25, 2025, 12:57
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 13, 2025, 11:33
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 11, 2025, 20:46
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Feb 11, 2025, 20:34
Compliances- Statement Of Deviation
Feb 11, 2025, 19:08
Integrated Filing (Financial)
Feb 11, 2025, 19:00
Results-Financial Results For The Quarter & Nine Months Ended 31St December 2024
Feb 11, 2025, 18:11
Board Meeting Outcome for Outcome Of The Board Meeting Held On 11Th February 2025
Feb 11, 2025, 17:55
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 07, 2025, 10:46
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 07, 2025, 10:44
Disclosures under Reg. 29(1) & 29 (2) of SEBI (SAST) Regulations 2011
Feb 07, 2025, 10:36
Board Meeting Intimation for Consideration Of Financial Results
Feb 05, 2025, 12:30
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Jan 31, 2025, 18:11
Announcement Under Regulation 30 Of SEBI LODR 2015
Jan 30, 2025, 12:43
Announcement Under Regulation 30 Of SEBI LODR 2015
Jan 30, 2025, 09:12
Announcement Under Regulation 30 Of LODR Regulations
Jan 16, 2025, 19:12
Change Of Name Of RTA
Jan 03, 2025, 15:03
Closure of Trading Window
Dec 27, 2024, 17:23
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011
Dec 23, 2024, 19:29
Company Entering Into A CDMO Contract With UK/ EU BasedCompanies
Dec 09, 2024, 17:20
Approval From Therapeutic Goods Administration (TGA), Australia
Dec 06, 2024, 17:37
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 16, 2024, 18:06
Investor Release
Nov 14, 2024, 21:44
Statement Of Deviation(S) Or Variation(S) Under Reg. 32
Nov 14, 2024, 21:33
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Nov 14, 2024, 21:31
Results For 30Th September, 2024
Nov 14, 2024, 21:25
Board Meeting Outcome for Outcome Of Board Meeting
Nov 14, 2024, 21:23
Board Meeting Intimation for Board Meeting To Be Held On 14Th November, 2024.
Nov 11, 2024, 16:53
Announcement Under Regulation 30 Of LODR Regulations
Oct 29, 2024, 16:46
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Oct 01, 2024, 19:51
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 30, 2024, 16:51
Closure of Trading Window
Sep 26, 2024, 18:10
Company Entering Into A Development And Supply Agreement For An Active Pharmaceutical Ingredient (API) With A European Entity
Sep 23, 2024, 12:12
Board Meeting Outcome for Outcome Of The Board Meeting Held On 19Th September, 2024
Sep 19, 2024, 13:52
Board Meeting Intimation for Meeting To Be Held On 19Th September, 2024
Sep 16, 2024, 16:31
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 07, 2024, 21:51
Book Closure For AGM
Sep 07, 2024, 24:02
Record Date
Sep 07, 2024, 24:00
Business Responsibility and Sustainability Reporting (BRSR)
Sep 06, 2024, 23:47
AGM Notice
Sep 06, 2024, 23:43
Reg. 34 (1) Annual Report.
Sep 06, 2024, 23:36
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 27, 2024, 12:00
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aug 20, 2024, 16:08
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 15, 2024, 17:55
Investor Release
Aug 15, 2024, 17:51
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th August, 2024
Aug 14, 2024, 19:08
Unaudited Financial Results For The Quarter Ended 30Th June, 2024.
Aug 14, 2024, 18:57
Board Meeting Intimation for Board Meeting To Be Held On 14Th August, 2024
Aug 08, 2024, 18:53

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
50.50
ATR(14)
Volatile
50.06
STOCH(9,6)
Neutral
51.19
STOCH RSI(14)
Neutral
61.68
MACD(12,26)
Bearish
-0.46
ADX(14)
Weak Trend
12.62
UO(9)
Bearish
51.22
ROC(12)
Downtrend And Accelerating
-0.48
WillR(14)
Neutral
-55.57